GLP-1 Receptor Agonist Shortage: American perspective Guidelines provided by the American Diabetes Association: During a shortage of GLP-1 receptor agonist therapy, alternative antihyperglycemic agents should be considered based on the patients needs and preferences
Physiol Rev 87(4):14091439 Holst JJ, Vilsbll T, Deacon CF (2009) The incretin system and its role in type 2 diabetes mellitus
doi: 10.3389/fphar.2022.969107 Received 14 June 2022 Accepted 12 September 2022 Published 03 October 2022 Volume 13 - 2022 Edited by Dan-Qian Chen, Northwest University, China Updates Copyright 2022 Chen, Ye, Wang, Liu, Wang, Wang, Xu and Gong
Zili You, University of Electronic Science and Technology of China, China Updates Copyright 2023 Iqbal, Huang, Xue, Yang and Jia
Nor is one automatically better than the other